December 25, 2025 a 12:46 pm
TMO: Dividend Analysis - Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. presents an intriguing dividend profile characterized by a strong growth trajectory and stable payout ratios. With a modest dividend yield, the company emphasizes reinvestment and robust financial management. Despite its relatively low yield, its dividend consistency over the years indicates a commitment to rewarding shareholders.
Overview 📊
Thermo Fisher Scientific Inc. operates within the Healthcare sector, offering a spectrum of services and products in the life sciences field. This company is marked by a 17-year streak of consistent dividend payments, which underscores its financial stability and operational resilience.
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Dividend yield | 0.30% |
| Current dividend per share | 1.53 USD |
| Dividend history | 17 years |
| Last cut or suspension | 2012 |
Dividend History 📉
The historical patterns of Thermo Fisher's dividends highlight a commitment to incremental growth. The consistency over 17 years reflects robust operational capabilities and prudent financial management. Such a history is crucial for investors seeking income stability.
| Year | Dividend per Share (USD) |
|---|---|
| 2025 | 1.72 |
| 2024 | 1.56 |
| 2023 | 1.40 |
| 2022 | 1.20 |
| 2021 | 1.04 |
Dividend Growth 📈
Thermo Fisher has demonstrated an appreciable capacity for dividend growth. The growth figures over 3 and 5 years suggest a strategy centered on gradual yet reliable increases, benefiting long-term shareholders.
| Time | Growth |
|---|---|
| 3 years | 14.47% |
| 5 years | 15.47% |
The average dividend growth is 15.47% over 5 years. This shows moderate but steady dividend growth.
Payout Ratio ✅
The payout ratio is crucial in ensuring that a company can sustain its dividend payments. Thermo Fisher has an EPS payout ratio of 8.78% and a free cash flow-based payout ratio of 9.47%, both of which indicate a conservative approach to dividend distribution, allowing for ample reinvestment into growth initiatives.
| Key figure | Ratio |
|---|---|
| EPS-based | 8.78% |
| Free cash flow-based | 9.47% |
The relatively low payout ratios suggest that Thermo Fisher prioritizes business reinvestment while maintaining shareholder returns.
Cashflow & Capital Efficiency
Cash flow and capital efficiency metrics provide insights into the operational efficiency of a company. Thermo Fisher's ratios reflect a balanced approach, combining effective capital allocation with sustainable operational cash flow management.
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Free Cash Flow Yield | 3.66% | 3.38% | 3.20% |
| Earnings Yield | 3.19% | 2.93% | 3.22% |
| CAPEX to Operating Cash Flow | 16.15% | 17.59% | 24.50% |
| Stock-based Compensation to Revenue | 0.70% | 0.65% | 0.68% |
| Free Cash Flow / Operating Cash Flow Ratio | 83.85% | 82.41% | 75.50% |
The figures indicate a solid capacity to generate cash flow with effective capital use, ensuring operational resilience and capital efficiency.
Balance Sheet & Leverage Analysis
Analyzing the balance sheet and leverage metrics helps gauge the company's financial health and debt management. Thermo Fisher evidences prudent leverage strategies with manageable debt ratios.
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Debt-to-Equity | 0.66 | 0.78 | 0.82 |
| Debt-to-Assets | 0.34 | 0.37 | 0.37 |
| Debt-to-Capital | 0.40 | 0.44 | 0.45 |
| Net Debt to EBITDA | 2.44 | 2.53 | 2.31 |
| Current Ratio | 1.66 | 1.75 | 1.48 |
| Quick Ratio | 1.29 | 1.39 | 1.15 |
The stable leverage ratios suggest a strong ability to honor debt obligations, with financial leverage used judiciously to support growth without overspending.
Fundamental Strength & Profitability 🗣️
Thermo Fisher's fundamentals illustrate not only its profitability but also operational efficiency, with consistently strong return metrics and robust margins.
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Return on Equity | 12.78% | 12.83% | 15.80% |
| Return on Assets | 6.51% | 6.07% | 7.15% |
| Margins: Net | 14.77% | 13.99% | 15.47% |
| EBIT Margin | 20.27% | 18.17% | 19.06% |
| EBITDA Margin | 27.52% | 26.12% | 26.59% |
| Gross Margin | 41.34% | 40.12% | 42.33% |
| Research & Development to Revenue | 3.24% | 3.12% | 3.28% |
The company's profitability and operational efficiency are mirrored in its strong fundamental metrics, which underpin its capability to maintain competitive advantages in the market.
Price Development
Dividend Scoring System ✨
| Criterion | Score | Score Bar |
|---|---|---|
| Dividend Yield | 2 | |
| Dividend Stability | 5 | |
| Dividend Growth | 4 | |
| Payout Ratio | 5 | |
| Financial Stability | 4 | |
| Dividend Continuity | 5 | |
| Cashflow Coverage | 3 | |
| Balance Sheet Quality | 4 |
Total Score: 32/40
Rating 🌟
Thermo Fisher Scientific Inc. demonstrates a solid dividend profile supported by stable growth, effective earnings reinvestment, and financial rigor. With a reliable history of dividends and sustainable financial practices, Thermo Fisher stands as a robust investment for those seeking steady income with moderate capital appreciation potential.